Deal of the Day — limited-time pharmacy picks!
Furmecil 15mg Capsule

Furmecil 15mg Capsule

Prescription requiredRx Required

Salt Composition: Tegafur Gimeracil Oteracil

Expiry Date: 01/2028

Special offer

Buy at $50.62

$50.62

Inclusive of all taxes

▼

7 Capsule in Strip

About The Product

Breast Cancer, Gastric Cancer, Colorectal Cancer


Description

Furmecil 15mg Capsule is a medicine prescribed by the doctor to treat advanced gastric (stomach) cancer, often in combination with other medicine. It sometimes also treats Colorectal and Pancreatic Cancer.

Furmecil 15mg Capsule a combination of three salts Tegafur, Gimeracil and Oteracil that inhibit cancer cell proliferation and growth by interuppting various growth mechanisms.

Uses

  • Advanced Gastric Cancer

Side Effects

Furmecil 15mg Capsule is a chemical salt based anticancer medication.Therefore,it has several common side effects like any other medicine.Consult your doctor, if side effects persist for longer period of time.

  • Bone marrow suppression
  • Diarrhea
  • Dehydration
  • Nausea
  • Vomiting
  • Kidney problems or acute renal failure
  • Electrolyte imbalance
  • Excessive Tearing
  • Nerve issues (numbness, tingling in hands/feet)
  • Hair loss and skin rash
  • Indigestion
  • Fatigue
  • Dizziness

How To Use

  • Furmecil 15mg Capsule is taken orally with water without breaking, chewing or biting the capsule.It should be taken on empty stomach.
  • Follow the doctor's prescribed dosage and time.​​

How It Works

Tegafur is converted into 5-fluorouracil (5-FU), which acts by inhibiting thymidylate synthase, thereby obstructing DNA and RNA synthesis in rapidly proliferating cancer cells; gimeracil enhances the levels of 5-FU by preventing its degradation, whereas oteracil mitigates gastrointestinal toxicity.

Safety Advice

Alcohol
It is advisable not to consume alcohol while taking Furmecil 15mg Capsule as it can worsen the side effects. It is advised to consult your doctor for further information
Pregnancy
Furmecil 15mg Capsule is considered unsafe for pregnancy due to fetal harm and teratogenic nature. Please consult your doctor in such condition
Breast Feeding
Breast Feeding is not advisable during the Furmecil 15mg Capsule Course. Consult your Doctor for more information
Driving
It is advisable not to drive, as you may feel dizzy after taking Furmecil 15mg Capsule
Kidney
Share your medical history related to kidney cancer or any other issue with your doctor before taking Furmecil 15mg Capsule
Liver
Notify your doctor about any liver disease or infection before starting Furmecil 15mg Capsule course

FAQs

Furmecil 15mg Capsule cause harm to growing fetus as well as is teratogenic in nature.

Thus, it is not recommended during pregnancy for treatment.

References

  • Kobayakawa, M., & Kojima, Y. (2011). Tegafur/gimeracil/oteracil (S-1) approved for the treatment of advanced gastric cancer in adults when given in combination with cisplatin: a review comparing it with other fluoropyrimidine-based therapies. OncoTargets and therapy, 193-201. https://pubmed.ncbi.nlm.nih.gov/22162925/
  • Matt, P., van Zwieten‐Boot, B., Calvo Rojas, G., Ter Hofstede, H., Garcia‐Carbonero, R., Camarero, J., ... & Pignatti, F. (2011). The European Medicines Agency review of Tegafur/Gimeracil/Oteracil (Teysuno™) for the treatment of advanced gastric cancer when given in combination with cisplatin: summary of the Scientific Assessment of the Committee for medicinal products for human use (CHMP). The Oncologist, 16(10), 1451-1457. https://pubmed.ncbi.nlm.nih.gov/21963999/
  • Kinoshita, T., Nashimoto, A., Yamamura, Y., Okamura, T., Sasako, M., Sakamoto, J., ... & Nakajima, T. (2004). Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil, oteracil potassium) for gastric cancer. Gastric Cancer, 7(2), 104-109. https://pubmed.ncbi.nlm.nih.gov/15224197/

  • Zhang, X., Tian, X., Wei, Y., Deng, H., Ma, L., & Chen, Z. (2021). Activity and Safety of Tegafur, Gimeracil, and Oteracil Potassium for Nasopharyngeal Carcinoma: A Systematic Review and Meta‐Analysis. Journal of Oncology, 2021(1), 6690275.

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026